Oncolytics Biotech Inc.
ONCY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $197 | $96 | $67 | $100 |
| - Cash | $12 | $15 | $15 | $16 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $186 | $82 | $53 | $85 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15 | -$6 | -$7 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$6 | -$7 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0.068 | -0.079 | -0.1 |
| % Growth | -106.8% | 14.3% | 21% | – |
| Operating Cash Flow | -$7 | -$5 | -$6 | -$8 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$7 | -$5 | -$6 | -$8 |